November 20, 2026
Six UPMC Hillman Cancer Center members have been named to this year’s list of Clarivate™ Highly Cited Researchers: Tullia Bruno, Greg Delgoffe, Valerian Kagan, John Kirkwood, Dario Vignali, and Simon Watkins.
They join an elite group that demonstrates significant and broad influence in their field of research. Each researcher selected has authored multiple Highly Cited Papers™ that rank in the top 1% body citations for their field(s) and publication year in the Web of Science, Clarivate's collection of journal citations, over the past eleven years. Citation activity is not the sole selection indicator; it is complemented by qualitative analysis and expert judgment to assess community-wide recognition from an international network of citing authors.
Clarivate honored 7,090 researchers spanning 62 countries and regions this year. Of Pitt's twenty-five researchers named to the list this year, more information about each of UPMC Hillman Cancer Center’s six follows (Affiliation at the time of recognition).
Tullia Bruno, PhD
Dr. Bruno studies the role of B cells in anti-tumor immunity. Her research maps how B cells and the tertiary lymphoid structures they form within tumors shape that response, combining single-cell sequencing, multispectral imaging, and spatial transcriptomics to guide development of B cell-directed immunotherapies. Dr. Bruno is a member of the Cancer Immunology and Immunotherapy Program and director of the Cytometry Facility at UPMC Hillman Cancer Center.
Greg Delgoffe, PhD
Dr. Delgoffe studies the intersection of metabolism and immunity in cancer. His research focuses on how nutrient deprivation in the tumor environment drives cell exhaustion, effectively starving tumor-infiltrating T cells and preventing their function. Dr. Delgoffe's work has advanced the understanding of how metabolic pathways influence therapies, such as immunotherapy. He is associate director for Basic Research at UPMC Hillman Cancer Center.
Valerian Kagan, PhD, DSc
Dr. Kagan is one of the world’s foremost authorities in free radical biology and medicine, internationally recognized for pioneering the field of oxidative lipidomics. His interdisciplinary research has deepened the understanding of how enzymes in oxidative metabolism produce lipid molecules that signal cell death and help clear damaged or dead cells. At UPMC Hillman Cancer Center, Dr. Kagan is a leading member of the Genome Stability Program, where his work helps elucidate how oxidative stress and lipid peroxidation shape genomic integrity, cell fate decisions, and tissue resilience.
John Kirkwood, MD
Dr. Kirkwood's research focuses on melanoma immunobiology, therapy, and prevention. His translational studies established the first effective adjuvant therapy of melanoma, identified the immunological basis of this therapy, and are now probing the role of molecularly targeted agents that may improve the efficacy of anti-PD1 immunotherapy. Dr. Kirkwood is a member of the Cancer Immunology and Immunotherapy Program and the director of the Melanoma Disease Center at UPMC Hillman Cancer Center.
Dario Vignali, PhD
Dr. Vignali's research focuses on understanding the inhibitory mechanisms, including inhibitory receptors and regulatory T cells, that limit anti-tumor immunity in cancer patients. He oversees discovery-based programs working to identify novel targets for therapeutic intervention and facilitate the translation of novel therapeutic modalities. Dr. Vignali is the Frank Dixon Chair in Cancer Immunology at the University of Pittsburgh and co-leader of the Cancer Immunology and Immunotherapy Program at UPMC Hillman Cancer Center.
Simon Watkins, PhD
Dr. Watkins develops, builds, and applies computer-aided microscopes and analysis tools to image subcellular events in fixed and living systems at all levels of resolution. He is the founder and director of the Center for Biology Imaging at the University of Pittsburgh — one of the largest optical imaging centers in the country. He serves as the director of the Cell and Tissue Imaging Facility, a shared resource for UPMC Hillman Cancer Center.
Visit Clarivate's website to access the full 2026 Highly Cited Researchers list and browse previous years’ archives.